Site Search Changing the landscape in Life-Threatening Diseases At Reata Pharmaceuticals, our mission is to develop innovative therapies that change patients’ lives for the better. showing 1-2 of 3 Committed to Making a Positive Impact Reata is focused on developing novel therapies for life threatening diseases that have few or no treatment options. Learn More Focused on Cellular Metabolism & Inflammation Chronic, unresolved inflammation and impaired cellular metabolism are key features of many diseases. Learn More Slide 1 Slide 2 Our Pipeline Reata’s development programs have created a robust pipeline of drug candidates for the treatment of serious, life-threatening diseases. Find out more here. Pipeline Discovery Preclinical Phase 1 Phase 2 Pivotal NDA* CHRONIC KIDNEY DISEASE Alport Syndrome | Bardoxolone* Autosomal Dominant Polycystic Kidney Disease | Bardoxolone IgA Nephropathy | Bardoxolone Type 1 Diabetes | Bardoxolone Focal Segmental Glomerulosclerosis | Bardoxolone At Risk of Rapid Progression | Bardoxolone NEUROLOGY Friedreich's Ataxia | Omaveloxolone** Diabetic Peripheral Neuropathic Pain | RTA 901 Bardoxolone = Bardoxolone methyl; *NDA accepted for filing by the FDA; **Subject to discussion with regulatory authorities Bardoxolone methyl, omaveloxolone, and RTA 901 are investigational drugs. Safety and efficacy have not been established by any agency. Latest News November 18, 2021 Reata Pharmaceuticals Receives Fast Track Designation From the FDA for Omaveloxolone for the Treatment of Friedreich’s Ataxia November 8, 2021 Reata Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results and Provides an Update on Clinical Development Programs November 1, 2021 Reata Pharmaceuticals, Inc. to Report Third Quarter 2021 Financial Results and to Provide an Update on Development Programs on November 8, 2021 October 28, 2021 Reata Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Bardoxolone Methyl in Chronic Kidney Disease Caused by Alport Syndrome More News Careers We are a team of problem solvers, trailblazers, and people who want to make a difference. Learn More Stay Connected Twitter opens in a new window Linkedin opens in a new window Facebook opens in a new window Instagram opens in a new window © Reata Pharmaceuticals, Inc. 2021, All Rights Reserved. Sitemap Legal Message Privacy Notice Social Media Disclosure Contact Us Powered By Q4 Inc. 5.66.0.1 (opens in new window) By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Privacy Policy Cookies Settings Reject All Accept All Cookies